Stocks and Investing Stocks and Investing
Mon, December 6, 2021
Sat, December 4, 2021
Fri, December 3, 2021
Thu, December 2, 2021
Wed, December 1, 2021
Tue, November 30, 2021

Michael Okunewitch Initiated (ATAI) at Strong Buy and Held Target at $25 on, Nov 30th, 2021


Published on 2024-10-27 18:48:53 - WOPRAI, Michael Okunewitch
  Print publication without navigation


Michael Okunewitch of Maxim Group, Initiated "Atai Life Sciences N.V." (ATAI) at Strong Buy and Held Target at $25 on, Nov 30th, 2021.

Michael has made no other calls on ATAI in the last 4 months.



There are 6 other peers that have a rating on ATAI. Out of the 6 peers that are also analyzing ATAI, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $17 on, Tuesday, November 16th, 2021


These are the ratings of the 5 analyists that currently disagree with Michael


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Monday, November 22nd, 2021
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $24 on, Tuesday, November 16th, 2021
  • Elemer Piros of "Roth Capital" Initiated at Strong Buy and Held Target at $32 on, Thursday, November 11th, 2021
  • Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 1st, 2021
  • Nathan Weinstein of "Argus Research" Maintained at Strong Buy with Increased Target to $27 on, Tuesday, August 17th, 2021